EUVIMEDEUVIMED entdecken
Crossref

Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19

Jheng-Yan Wu iD, Mei-Yuan Liu, Ting-Hui Liu, Min-Hsiang Chuang, Wan-Hsuan Hsu, Po-Yu Huang iD, Ya-Wen Tsai iD, Chia-Yin Kuo, Chun-Ting Yeh, Chih-Cheng Lai iD

Journal of Medical Virology · 2023

DOI: 10.1002/jmv.28866 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2023. Verfasst von Jheng-Yan Wu und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan. Hauptthemen laut MEDLINE: COVID-19, Diabetes Mellitus. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 37 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this study was to investigate the clinical efficacy of a combination of nirmatrelvir and ritonavir (NMV‐r) for treating COVID‐19 in patients with diabetes mellitus (DM). This retrospective cohort study used the TriNetX research network to identify adult diabetic patients with COVID‐19 between January 1, 2020, and December 31, 2022. Propensity score matching was used to match patients who received NMV‐r (NMV‐r group) with those who did not receive NMV‐r (control group). The primary outcome was all‐cause hospitalization or death during the 30‐day follow‐up period. Two cohorts comprising 13 822 patients with balanced baseline characteristics were created using propensity score matching. During the follow‐up period, the NMV‐r group had a lower risk of all‐cause hospitalization or death than the control group (1.4% [ n = 193] vs. 3.1% [ n = 434]; hazard ratio [HR], 0.497; 95% confidence interval [CI], 0.420–0.589). Compared with the control group, the NMV‐r group also had a lower risk of all‐cause hospitalization (HR, 0.606; 95% CI, 0.508–0.723) and all‐cause mortality (HR, 0.076; 95% CI, 0.033–0.175). This lower risk was consistently observed in almost all subgroup analyses, which examined sex (male: 0.520 [0.401–0.675]; female: 0.586 [0.465–0.739]), age (age 18–64 years: 0.767 [0.601–0.980]; ≥65 years: 0.394 [0.308–0.505]), level of HbA1c (

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Diabetes MellitusAdultHumansFemaleMaleAdolescentYoung AdultMiddle AgedRetrospective StudiesRitonavirCOVID-19 Drug TreatmentTreatment OutcomeLactamsLeucineNitrilesProline

Stichwörter der Autor:innen

COVID-19SARS-CoV-2diabetes mellitushospitalizationmortalitynirmatrelvir and ritonavir combination

Substanzen

RitonavirnirmatrelvirLactamsLeucineNitrilesProline

Autor:innen und Institutionen

  • Department of Nutrition, Chi Mei Medical Center, Tainan, Taiwan.
  • Graduate Institute of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan.
  • Department of Nutrition and Health Sciences, Chang Jung Christian University, Tainan, Taiwan.
  • Department of Food Nutrition, Chung Hwa University of Medical Technology, Tainan, Taiwan.
  • Department of Psychiatry, Chi Mei Medical Center, Tainan, Taiwan.
  • Department of Internal Medicine, Chi Mei Medical Center, Tainan, Taiwan.

ORCID-Profile: Jheng-Yan Wu, Po-Yu Huang, Ya-Wen Tsai, Chih-Cheng Lai

Zitieren

APA

Wu, J. Y., Liu, M. Y., Liu, T. H., Chuang, M. H., Hsu, W. H., Huang, P. Y., Tsai, Y. W., Kuo, C. Y., Yeh, C. T., & Lai, C. C. (2023). Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19. Journal of Medical Virology. https://doi.org/10.1002/jmv.28866

Vancouver

Wu JY, Liu MY, Liu TH, Chuang MH, Hsu WH, Huang PY, et al. Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19. Journal of Medical Virology. 2023. doi:10.1002/jmv.28866

BibTeX
@article{Wu2023,
  author = {Wu, Jheng-Yan and Liu, Mei-Yuan and Liu, Ting-Hui and Chuang, Min-Hsiang and Hsu, Wan-Hsuan and Huang, Po-Yu and Tsai, Ya-Wen and Kuo, Chia-Yin and Yeh, Chun-Ting and Lai, Chih-Cheng},
  title = {Clinical efficacy of nirmatrelvir and ritonavir combination for treating diabetic patients with COVID‐19},
  journal = {Journal of Medical Virology},
  year = {2023},
  doi = {10.1002/jmv.28866}
}
Kostenlos starten →